Lexaria Bioscience (LEXX)
US Market

Lexaria Bioscience (LEXX) Financial Statements


Lexaria Bioscience Financial Overview

Lexaria Bioscience's market cap is currently ―. The company's EPS TTM is $-1.128; its P/E ratio is -2.74; Lexaria Bioscience is scheduled to report earnings on April 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 23Aug 23May 23Feb 23Nov 22
Income Statement-
Total Revenue$ 151.28K$ -104.91K$ 93.15K$ 35.02K$ 101.48K
Gross Profit$ 146.46K$ -104.91K$ 80.40K$ 32.06K$ 85.68K
EBIT$ -1.19M$ -1.35M$ -2.38M$ -1.31M$ -1.77M
EBITDA$ -1.16M$ -1.28M$ -2.36M$ -1.29M$ -1.74M
Net Income Common Stockholders$ -1.18M$ -1.34M$ -2.37M$ -1.30M$ -1.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.03M$ 1.48M$ 3.43M$ 3.54M$ 4.80M
Total Assets$ 3.63M$ 3.08M$ 5.24M$ 4.85M$ 6.21M
Total Debt$ 155.07K$ 163.97K$ 174.90K$ 29.08K$ 39.63K
Net Debt$ -1.87M$ -1.31M$ -3.26M$ -3.51M$ -4.76M
Total Liabilities$ 254.04K$ 403.91K$ 1.20M$ 223.13K$ 281.52K
Stockholders Equity$ 3.74M$ 3.04M$ 4.40M$ 4.97M$ 6.26M
Cash Flow-
Free Cash Flow$ -1.22M$ -1.69M$ -4.36M$ -1.27M$ -1.27M
Operating Cash Flow$ -1.18M$ -1.62M$ -4.26M$ -1.24M$ -1.23M
Investing Cash Flow$ -40.03K$ -68.44K$ -101.17K$ -32.68K$ -34.84K
Financing Cash Flow$ 1.82M$ -121.69K$ 1.71M$ 11.20K$ -11.20K
Currency in USD

Lexaria Bioscience Earnings and Revenue History

Lexaria Bioscience Debt to Assets

Lexaria Bioscience Cash Flow

Lexaria Bioscience Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis